Tag Archives: Supreme Court

Supreme Court to Review Monsanto v. Bowman

Posted on October 8, 2012 by Warren Woessner

On Friday, Oct 5th, the Supreme Court granted cert. to review the Fed. Cir.’s decision in Monsanto Co. v. Bowman, App. no. 2010-1068 (Fed. Cir. September 21, 2011). (A copy of the decision is at the end of this post.) … Continue reading →

Posted in Ag Biotechnology, Exhaustion of Rights | Tagged , , , , , , , , , , , , , , | Leave a comment

PERSONALIZED MEDICINE TAKES OFF WHILE DIAGNOSTIC ASSAYS ARE GROUNDED

Posted on September 25, 2012 by Warren Woessner

A front-page article yesterday in the New York Times and other major newspapers reminded me that drug development and methods of medical treatment will be driven by the genomics of increasingly sub-divided patient populations. As reported by GenomeWeb, summarizing an … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

Federal Circuit Opinion On Myriad Remand

Posted on August 16, 2012 by Warren Woessner

Today, the Federal Circuit issued its opinion following GVR from the Supreme Court in AMP v. USPTO and Myriad Genetics, Inc., App. No. 2010-1406 (August 16,2012). (A copy of the opinion is available at the end of this post.) Unfortunately, … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | 1 Comment

PTO Guidelines for Process Claims Involving Laws of Nature

Posted on July 8, 2012 by Warren Woessner

On July 3rd, the PTO released 13 pages entitled “2012 Interim Procedure for Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature.” They are intended as guidance for Examiners who encounter such claims, e.g., in Group 1600, in … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , | 1 Comment